麻豆传媒

The backstory of to clinical relevance. (MIT Technology Review)

Adding an immune system booster to a personalized cancer vaccine enhanced . (UCLA Health Jonsson Comprehensive Cancer Center, Nature Communications)

The FDA has told drug companies to spend more time on to reduce side effects. (Washington Post)

Nearly half of cancer patients and survivors , according to the American Cancer Society.

Eight years after his death, a cancer researcher gets his due for to advance treatment. (UVAToday)

Combining radiation therapy (RT) with hormonal therapy may in prostate cancer and help men avoid side effects. (Institute for Cancer Research)

Merck announced that adjuvant pembrolizumab (Keytruda) plus chemotherapy, with or without RT, in high-risk endometrial cancer as compared with placebo plus chemotherapy, with or without RT.

The dramatic increase in has expanded into teenagers. (NBC News)

engaged in price negotiations with Medicare, Merck was the only one that spent more on research and development than it did on executive compensation, marketing, administration, and shareholder payments, according to a report. (The Hill)

A modification to standard CAR T-cell therapy, currently used to treat blood cancers, significantly . (Montefiore Einstein Comprehensive Cancer Center, Science Advances)

Integrating a screening tool for tripled the number of patients actually referred, as compared with historical rates. (University of Pittsburgh Hillman Cancer Center)

Participants in a National Comprehensive Cancer Network policy summit encouraged more emphasis on how affect people with cancer.

Bispecific T-cell engagers are poised to become the next . (GlobalData)

Comment